Thyroid Cancer Diagnosis and Treatment
Thyroid Cancer Diagnosis and Treatment is a research topic within Endocrinology, Diabetes and Metabolism. Science Explorer counts 43k research works in it since 1950. 13.2% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the management, diagnosis, and molecular genetics of thyroid cancer, including differentiated and medullary thyroid carcinoma. It covers topics such as the management guidelines for thyroid nodules, the role of BRAF mutation in papillary thyroid carcinoma, ultrasound imaging for thyroid nodules, and the use of radioactive iodine therapy. The cluster also discusses the molecular pathogenesis and genetic alterations associated with thyroid cancer.
- Thyroid Nodules
- Differentiated Thyroid Cancer
- Management Guidelines
- Thyroid Carcinoma
- BRAF Mutation
- Ultrasound
- Radioactive Iodine Therapy
- Molecular Genetics
- Medullary Thyroid Cancer
- Fine-Needle Aspiration
- Research works
- 43k fractional, since 1950
- In the world top 10%
- 5.6k per year above
- Top-10% rate
- 13.2% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +26% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Thyroid Cancer Diagnosis and Treatment research?
By volume, China and the United States publish the most (2k and 1.4k works in 2022–2025).
By volume, 2022–2025
- 1 China 2k works
- 2 United States 1.4k works
- 3 India 492 works
- 4 Italy 383 works
- 5 South Korea 319 works
- 6 Türkiye 297 works
- 7 Japan 256 works
- 8 Germany 183 works
- 9 United Kingdom 179 works
- 10 France 168 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Thyroid Cancer Diagnosis and Treatment research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Thyroid Cancer Diagnosis and Treatment research, followed by Memorial Sloan Kettering Cancer Center and The University of Texas MD Anderson Cancer Center.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 57 works
- 2 Memorial Sloan Kettering Cancer CenterUnited States 35 works
- 3 The University of Texas MD Anderson Cancer CenterUnited States 35 works
- 4 Sichuan UniversityChina 33 works
- 5 China Medical UniversityChina 31 works
- 6 University of PisaItaly 29 works
- 7 West China Hospital of Sichuan UniversityChina 29 works
- 8 Sun Yat-sen UniversityChina 28 works
- 9 Sağlık Bilimleri ÜniversitesiTürkiye 28 works
- 10 Shanghai Jiao Tong UniversityChina 28 works
Who are the leading researchers in Thyroid Cancer Diagnosis and Treatment?
The most-cited researchers publishing on Thyroid Cancer Diagnosis and Treatment include Luigi Ferrucci, John C. Morris and M. Yılmaz.
- 1 Luigi Ferrucci United States 5.3k citations
- 2 John C. Morris United States 5.1k citations
- 3 M. Yılmaz Azerbaijan 4.7k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Thyroid Cancer Diagnosis and Treatment research done?
The largest centres of Thyroid Cancer Diagnosis and Treatment research in 2022–2025 are Beijing (China), Seoul (South Korea), Shanghai (China) and Hangzhou (China).
Largest cities, 2022–2025
Where is the best place to study Thyroid Cancer Diagnosis and Treatment?
Among universities, judged by research, China Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College and Ulsan College score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | China Medical UniversityChina | 60.2 | 19.4% | 12.1× | 31 | +35.4% |
| 2 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 55.8 | 11.4% | 7.4× | 57 | +73.4% |
| 3 | Ulsan CollegeSouth Korea | 55.4 | 23.0% | 12.4× | 10 | +87.9% |
| 4 | Catholic University of KoreaSouth Korea | 55.0 | 22.2% | 12.7× | 18 | -20.1% |
| 5 | University of PisaItaly | 52.9 | 18.0% | 7.9× | 29 | +8.7% |
| 6 | University of Alabama at BirminghamUnited States | 51.5 | 27.2% | 3.6× | 14 | +329.6% |
| 7 | Fujian Medical UniversityChina | 49.5 | 14.6% | 8.8× | 25 | +14.2% |
| 8 | Victor Babeș University of Medicine and Pharmacy TimișoaraRomania | 48.2 | 15.8% | 16.1× | 12 | +45.8% |
| 9 | University of Health Sciences AntiguaAntigua and Barbuda | 48.2 | 6.6% | 10.9× | 10 | — |
| 10 | Capital Medical UniversityChina | 47.9 | 14.9% | 4.9× | 23 | +166.5% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Thyroid Cancer Diagnosis and Treatment research growing?
Output in 2018–2022 was 26% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Thyroid Cancer Diagnosis and Treatment.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.